BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25182711)

  • 1. Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer.
    Krajewski J; Bode-Böger SM; Tröger U; Martens-Lobenhoffer J; Mulrooney T; Mittelstädt H; Russlies M; Kirchner R; Knobloch JK
    Int J Antimicrob Agents; 2014 Oct; 44(4):363-6. PubMed ID: 25182711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-stage approach to total knee arthroplasty using colistin-loaded articulating cement spacer for vancomycin-resistant Pseudomonas aeruginosa infection in an arthritic knee.
    Chang MJ; Song MK; Shin JH; Yoon C; Chang CB; Kang SB
    Eur J Orthop Surg Traumatol; 2019 Jan; 29(1):227-230. PubMed ID: 29915953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
    Quinn AL; Parada JP; Belmares J; O'Keefe JP
    Ann Pharmacother; 2005 May; 39(5):949-52. PubMed ID: 15811909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological efficacy of colistin therapy in combination with rifampin and imipenem in multidrug-resistant Pseudomonas aeruginosa diabetic foot infection with osteomyelitis.
    Tascini C; Menichetti F; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Piaggesi A
    Int J Low Extrem Wounds; 2006 Sep; 5(3):213-6. PubMed ID: 16928678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.
    Berlana D; Llop JM; Manresa F; Jódar R
    Pharmacotherapy; 2011 Feb; 31(2):146-57. PubMed ID: 21275493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis.
    Tascini C; Gemignani G; Palumbo F; Leonildi A; Tedeschi A; Lambelet P; Lucarini A; Piaggesi A; Menichetti F
    J Chemother; 2006 Dec; 18(6):648-51. PubMed ID: 17267344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline.
    Stanzani M; Tumietto F; Giannini MB; Bianchi G; Nanetti A; Vianelli N; Arpinati M; Giovannini M; Bonifazi F; Bandini G; Baccarani M
    J Med Microbiol; 2007 Dec; 56(Pt 12):1692-1695. PubMed ID: 18033842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.
    Yamada T; Ishiguro N; Oku K; Higuchi I; Nakagawa I; Noguchi A; Yasuda S; Fukumoto T; Iwasaki S; Akizawa K; Furugen A; Yamaguchi H; Iseki K
    Biol Pharm Bull; 2015; 38(9):1430-3. PubMed ID: 26155936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
    J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients.
    Hachem RY; Chemaly RF; Ahmar CA; Jiang Y; Boktour MR; Rjaili GA; Bodey GP; Raad II
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1905-11. PubMed ID: 17387153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Güzel CB; Gerçeker AA
    Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.
    Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP
    J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.
    Taccetti G; Bianchini E; Cariani L; Buzzetti R; Costantini D; Trevisan F; Zavataro L; Campana S;
    Thorax; 2012 Oct; 67(10):853-9. PubMed ID: 22379071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of a multidrug-resistant Pseudomonas aeruginosa infected total knee arthroplasty using colistin. A case report and review of the literature.
    Papagelopoulos PJ; Mavrogenis AF; Giannitsioti E; Kikilas A; Kanellakopoulou K; Soucacos PN
    J Arthroplasty; 2007 Apr; 22(3):457-63. PubMed ID: 17400104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
    Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H
    Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou QT; Cheah SE; Zhao J; Chen K; Wang J; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The revival of colistin: an old antibiotic for the 21st century].
    Nasnas R; Saliba G; Hallak P
    Pathol Biol (Paris); 2009 May; 57(3):229-35. PubMed ID: 18178335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.